Novo Nordisk A/S

NOVOBC.XC·Cboe UK·Healthcare
Compare
284.000.00 (0.00%)today
As of Nov 4, 3:22 PM GMT · May be delayed up to 15 min · DKK

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close284.00
Open276.03
Day range—
52-week range228.65406.80
Off day high0.00%
Off 52-week high−30.19%
Volume887
Avg. volume (3M)485
Market cap1.26T
EPS (TTM)24.13
Forward P/E—
P/E ratio (TTM)11.77
Dividend yield4.35% (11.70)
Beta (5Y)0.37
Shares outstanding3.36B
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin35.35%

Against its peers

Compare in full ›
NOVOBC.XC LLY NVS BIIB 0QFP.IL 000640.KS
Market cap 1.26T 1.27T 309.37B 37.49B 4.46T 600.98B
P/E (TTM) 11.8 46.4 31.3 109.8 18.8 —
Forward P/E — 28.5 16.5 15.6 — —
Price/book 6.5 31.6 8.3 2.0 2.1 —
Dividend yield 4.35% 0.49% 2.87% — 7.74% 1.93%
1-year change −11.62% +51.26% +30.35% +62.35% 0.00% −15.76%
Today 0.00% +0.81% −0.71% −0.34% +156.25% +1.48%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Seeking Alpha·Positive

Novo Nordisk A/S (NOVO:CA) Q3 2026 Earnings Call Transcript

Novo Nordisk A/S (NOVO:CA) Q3 2026 Earnings Call November 4, 2026 7:00 AM ESTCompany ParticipantsMichael Novod - Senior VP & Head of Investor... Novo Nordisk A/S (NOVO:CA) Q3 2026 Earnings Call November 4, 2026 7:00 AM EST Michael Novod -…

MarketScreener·Positive

Novo Nordisk A/S : Jefferies remains Neutral

Published on 11/04/2026 at 03:47 am EST Novo Nordisk Reports Encouraging Results for CagriSema October 20, 2026 at 10:37 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads

From the 4Search news index, newest first.

In the news

25mentions in 30 days
25with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 25 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance